Irene Ni

1.1k total citations
15 papers, 743 citations indexed

About

Irene Ni is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Irene Ni has authored 15 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Irene Ni's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Irene Ni is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Irene Ni collaborates with scholars based in United States, Netherlands and United Kingdom. Irene Ni's co-authors include Wenwu Zhai, Arvind Rajpal, Jacob Glanville, Purnima Sundar, Jaume Pons, Li Mei, Dilduz Telman, David Cox, Jan Berka and Gabriella Huerta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Irene Ni

15 papers receiving 714 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Irene Ni 379 356 347 166 69 15 743
Marcia Stickler 445 1.2× 372 1.0× 358 1.0× 155 0.9× 41 0.6× 15 781
Geir Åge Løset 307 0.8× 310 0.9× 275 0.8× 160 1.0× 50 0.7× 33 712
Sebastian Spindeldreher 379 1.0× 739 2.1× 381 1.1× 151 0.9× 29 0.4× 25 1.0k
Fabrice Le Gall 650 1.7× 356 1.0× 495 1.4× 356 2.1× 36 0.5× 20 998
Anneke W. Reurs 441 1.2× 251 0.7× 479 1.4× 245 1.5× 26 0.4× 16 793
Carmela Mennuni 201 0.5× 311 0.9× 384 1.1× 147 0.9× 228 3.3× 24 781
Bernd Hubner 211 0.6× 256 0.7× 276 0.8× 73 0.4× 67 1.0× 15 579
Zoltan A. Nagy 412 1.1× 814 2.3× 340 1.0× 134 0.8× 87 1.3× 45 1.1k
Grete Sønderstrup 321 0.8× 554 1.6× 282 0.8× 121 0.7× 172 2.5× 30 1.1k
Gabriella Huerta 325 0.9× 410 1.2× 320 0.9× 70 0.4× 21 0.3× 5 736

Countries citing papers authored by Irene Ni

Since Specialization
Citations

This map shows the geographic impact of Irene Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Ni more than expected).

Fields of papers citing papers by Irene Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Ni. The network helps show where Irene Ni may publish in the future.

Co-authorship network of co-authors of Irene Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Ni. A scholar is included among the top collaborators of Irene Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Ni. Irene Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Greer, Renee L., Henry T. Nguyen, Ruth Y. Lan, et al.. (2022). 1083 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that mediates potent anti-tumor activity, cytotoxicity, and expansion of memory CD8+ T cells. Regular and Young Investigator Award Abstracts. A1125–A1125. 2 indexed citations
2.
Moynihan, Kelly D., Danielle C. Pappas, Hussein Sultan, et al.. (2022). 1092 The CD8+ T cell selectivity of AB248 is essential for optimal anti-tumor activity and safety in nonclinical models. Regular and Young Investigator Award Abstracts. A1135–A1135. 4 indexed citations
3.
Chen, Wei, Fan Yang, Jatin Narula, et al.. (2021). One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeutics. mAbs. 13(1). 1871171–1871171. 36 indexed citations
4.
Moynihan, Kelly D., Danielle C. Pappas, Wei Chen, et al.. (2021). 717 Selective activation of CD8+ T cells by a CD8-targeted IL-2 results in enhanced anti-tumor efficacy and safety. SHILAP Revista de lepidopterología. A746–A746. 5 indexed citations
5.
Yeung, Yik A., Veena Krishnamoorthy, Cesar Sommer, et al.. (2020). An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity. Molecular Therapy. 28(3). 889–900. 26 indexed citations
6.
Abdiche, Yasmina, Irene Ni, Donna M. Stone, et al.. (2017). Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another. PLoS ONE. 12(1). e0169535–e0169535. 30 indexed citations
7.
Yeung, Yik A., Davide Foletti, Xiaodi Deng, et al.. (2016). Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire. Nature Communications. 7(1). 13376–13376. 30 indexed citations
8.
Lee, Li‐Fen, Nikki van Driel, Jon D. Laman, et al.. (2015). Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology. 11(1). 73–83. 18 indexed citations
9.
Lee, Li‐Fen, Kathryn Logronio, Guang Huan Tu, et al.. (2012). Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proceedings of the National Academy of Sciences. 109(31). 12674–12679. 110 indexed citations
10.
Zhai, Wenwu, Jacob Glanville, Markus Fuhrmann, et al.. (2011). Synthetic Antibodies Designed on Natural Sequence Landscapes. Journal of Molecular Biology. 412(1). 55–71. 70 indexed citations
11.
Glanville, Jacob, Wenwu Zhai, Jan Berka, et al.. (2009). Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proceedings of the National Academy of Sciences. 106(48). 20216–20221. 339 indexed citations
12.
Sarup, Jay, Jin Pei, Xiaomei Bai, et al.. (2008). Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activityin vitroand in human tumor xenografts. Molecular Cancer Therapeutics. 7(10). 3223–3236. 28 indexed citations
13.
Pei, Jin, Juan Zhang, Percy F. Sumariwalla, et al.. (2008). Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. Arthritis Research & Therapy. 10(4). R73–R73. 33 indexed citations
14.
Sumariwalla, Percy F., Jin Pei, Juan Zhang, et al.. (2008). Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen‐induced arthritis. Arthritis & Rheumatism. 58(10). 3071–3080. 11 indexed citations
15.
Jackson, Alan A., et al.. (2003). Agarose gel size fractionation of RNA for the cloning of full-length cDNAs. Analytical Biochemistry. 323(2). 252–255. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026